(Q73954449)

English

Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-frühe Stadien

scientific article published on 01 December 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-frühe Stadien (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

M Stuschke

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Hoederath

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H Sack

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

R Pötter

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

R P Müller

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

U Schulz

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Karstens

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H B Makoski

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

0 references

publication date

1 December 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

80

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

2273-2284

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Treatment of early--stages I and II--nodular, poorly differentiated lymphocytic lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Prognostic factors in non-Hodgkin lymphoma stage I treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

The role of radiation therapy in the management of the non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Role of radiation therapy in localized non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Karnofsky memorial lecture. The low-grade non-Hodgkin's lymphomas: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Follicular lymphoma: prognostic factors for response and survival

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Low grade stage I and II non-Hodgkin's lymphoma: results of treatment and relapse pattern following therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Localized follicular lymphomas: prognosis and survival of stages I and II in a retrospective series of 103 patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

The role of radiation therapy in the management of stage III follicular lymphomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Stage III nodular lymphoreticular tumors (non-Hodgkin's lymphoma): Results of central lymphatic irradiation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Comprehensive lymphatic irradiation for stage II-III non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Updated Kiel classification for lymphomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Nodular malignant lymphomas.Factors affecting complete response rate and survival

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Low-grade follicular lymphomas: Analysis of prognosis in a series of 281 patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

The EORTC trials for limited stage Hodgkin's disease. The EORTC Lymphoma Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Histological, epidemiological and clinical aspects of centroblastic-centrocytic lymphomas subdivided according to the “working formulation”

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Recurrence Rates Following Radiation Therapy of Nodular and Diffuse Malignant Lymphomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

The follicular non-Hodgkin's lymphomas--I. The possibility of cure

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Effect of recombinant human granulocyte colony stimulating factor (R-metHuG-CSF) as an adjunct to large-field radiotherapy: a phase I study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Comparison of two strategies for the treatment of radiogenic leukopenia using granulocyte colony stimulating factor.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

CVP—Remission—maintenance in stage I or II non-Hodgkin's lymphomasPreliminary results of a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkins lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. EBMT Working Party for Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Phase I/II study with a weekly 24-hour infusion of 5-fluorouracil plus high-dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%3C2273%3A%3AAID-CNCR9%3E3.0.CO%3B2-V

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19971215)80:12<2273::AID-CNCR9>3.0.CO;2-V

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9404705%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73954449&oldid=1360628506"